"Ophthalmology practice specializing in retinal diseases"

During the past decade, Deep Blue Retina PLLC conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Deep Blue Retina PLLC" are "Diabetic Macular Edema" (2 trials), "Geographic Atrophy" (2 trials), "Diabetic Retinopathy" (1 trials) and "Macular Degeneration" (1 trials). Many other conditions were trialed in "Deep Blue Retina PLLC" in a lesser frequency.

Most popular intervention types in "Deep Blue Retina PLLC" are "Drug" (4 trials), "Other" (3 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "RO7200220" (2 trials), "Ranibizumab" (2 trials), "Sham Procedure" (2 trials) and "IONIS-FB-LRx" (1 trials). Other intervention names were less common.

The vast majority of trials in "Deep Blue Retina PLLC" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Deep Blue Retina PLLC". undefined are not yet recruiting, 2 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Deep Blue Retina PLLC, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Deep Blue Retina PLLC, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".